CTLA4 and neoplasm: Other strategies adopted by tumor cells are the upregulation of the so-called immune checkpoint molecules, such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) with its ligand (PD-L1) [44].